AU1176095A - Method of treatment using, process of preparing, and composition comprising a recombinant hsv-1 - Google Patents

Method of treatment using, process of preparing, and composition comprising a recombinant hsv-1

Info

Publication number
AU1176095A
AU1176095A AU11760/95A AU1176095A AU1176095A AU 1176095 A AU1176095 A AU 1176095A AU 11760/95 A AU11760/95 A AU 11760/95A AU 1176095 A AU1176095 A AU 1176095A AU 1176095 A AU1176095 A AU 1176095A
Authority
AU
Australia
Prior art keywords
preparing
treatment
composition
recombinant hsv
hsv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11760/95A
Inventor
Max Cynader
Francis Tufaro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Publication of AU1176095A publication Critical patent/AU1176095A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16641—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
AU11760/95A 1993-11-10 1994-11-10 Method of treatment using, process of preparing, and composition comprising a recombinant hsv-1 Abandoned AU1176095A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15047593A 1993-11-10 1993-11-10
US150475 1993-11-10
PCT/US1994/012996 WO1995013391A1 (en) 1993-11-10 1994-11-10 Method of treatment using, process of preparing, and composition comprising a recombinant hsv-1

Publications (1)

Publication Number Publication Date
AU1176095A true AU1176095A (en) 1995-05-29

Family

ID=22534695

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11760/95A Abandoned AU1176095A (en) 1993-11-10 1994-11-10 Method of treatment using, process of preparing, and composition comprising a recombinant hsv-1

Country Status (3)

Country Link
AU (1) AU1176095A (en)
CA (1) CA2176284A1 (en)
WO (1) WO1995013391A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804413A (en) * 1992-07-31 1998-09-08 University Of Pittsburgh Of The Commonwealth System Of Higher Education Herpes simplex virus strains for gene transfer
US5763217A (en) * 1993-11-10 1998-06-09 University Of British Columbia Method of using, process of preparing and composition comprising recombinant herpesvirus vectors
DE69535703T2 (en) 1994-04-13 2009-02-19 The Rockefeller University AAV-mediated delivery of DNA to cells of the nervous system
US5698431A (en) * 1995-02-09 1997-12-16 Washington University Herpes simplex virus mutant UL41NHB
US6261552B1 (en) 1997-05-22 2001-07-17 University Of Pittsburgh Of The Commonwealth System Of Higher Education Herpes simplex virus vectors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005780A1 (en) * 1988-11-18 1990-05-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Dopamine receptors and genes
CA2039921A1 (en) * 1990-04-16 1991-10-17 Xandra O. Breakefield Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication

Also Published As

Publication number Publication date
WO1995013391A1 (en) 1995-05-18
CA2176284A1 (en) 1995-05-18

Similar Documents

Publication Publication Date Title
AU4861493A (en) Clear leave-on treatment composition and method
AU6844694A (en) Novel process and apparatus
AU6097794A (en) Method of treating diabetes mellitus
AU6163194A (en) Apparatus and method for shaping bone
AU6430794A (en) A method of treating endo-osteal materials
AU6344794A (en) Consolidatable particulate material and well treatment method
AU616091B2 (en) Treatment process
AU7739394A (en) A composition and a method for the treatment of dyed fabric
AU6001094A (en) Tnf-alpha muteins and a process for preparing them
AU7056894A (en) Skin treatment method utilizing a composition and a pad
AU3369589A (en) Asbestos-treating agent and process for treating asbestos
AU2969189A (en) Composition and process for treating metal surfaces
AU4520893A (en) Sterilization process and composition
AU6703394A (en) Method of treating depression using neurotrophins
HU9401208D0 (en) 2-amino-4-quinoline-dihydropyridines, process for producing them and use of them
HU216713B (en) Cyclic-acetals and process for their preparation
AU6276094A (en) Apparatus and method for interstitial treatment
AU1176095A (en) Method of treatment using, process of preparing, and composition comprising a recombinant hsv-1
GB9304521D0 (en) Improved alumoxane,method for its preparation and polymerisation process using such alumoxane
AU1178395A (en) Method of treating muscular dystrophy
AU7786594A (en) Method and plant for grinding old brasques and similar products
AU6973294A (en) Method for treatment of a piece
AU6046294A (en) Process for producing human growth hormone
AU6810694A (en) Treating process gas
GB9420539D0 (en) Process and composition